SXT
VENTE TOTALE: 1 200 titres (~155 372,04 $ US)
- Insiders
- Ferruzzi Mario
- Total bought
- —
- Total sold
- $155,372
- Last activity
- 2026-08-05
- Last synced
-
2026-08-11 09:46:50
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-07
SXT benefits from a confirmed earnings catalyst (strong Q2 2026 beat, Zacks Strong Buy upgrade, ADAR1 Capital initiation) supported by solid liquidity (score: 85) and stable margins, producing a meaningful but not…
The first sentence of the analysis written for SXT on 2026-08-07 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 33.5% | 32.6% | 31.6% | 34.0% | 32.9% | |
| Ebit Margin | 12.8% | 12.3% | 10.6% | 13.7% | 12.3% | |
| Ebitda Margin | 16.6% | 16.2% | 14.6% | 17.3% | 16.1% | |
| Operating Profit Margin | 12.8% | 12.3% | 10.6% | 13.7% | 12.3% | |
| Pretax Profit Margin | 11.0% | 10.5% | 8.9% | 12.7% | 11.4% | |
| Continuous Operations Profit Margin | 8.3% | 8.0% | 6.4% | 9.8% | 8.6% | |
| Net Profit Margin | 8.3% | 8.0% | 6.4% | 9.8% | 8.6% | |
| Bottom Line Profit Margin | 8.3% | 8.0% | 6.4% | 9.8% | 8.6% | |
| Current Ratio | 4.103 | 3.554 | 3.964 | 3.435 | 3.190 | |
| Quick Ratio | 1.530 | 1.336 | 1.431 | 1.362 | 1.418 | |
| Solvency Ratio | 0.186 | 0.192 | 0.157 | 0.197 | 0.212 | |
| Cash Ratio | 0.139 | 0.098 | 0.122 | 0.077 | 0.111 | |
| Price To Earnings Ratio | 29.544 | 24.074 | 29.730 | 21.702 | 35.482 | |
| Price To Earnings Growth Ratio | 3.975 | 0.722 | -0.876 | 1.133 | 3.996 | |
| Forward Price To Earnings Growth Ratio | 3.975 | 0.722 | -0.876 | 1.133 | 3.996 | |
| Price To Earnings Diluted Ratio | 29.731 | 24.238 | 29.864 | 21.832 | 35.609 | |
| Price To Earnings Diluted Growth Ratio | 3.973 | 0.734 | -0.883 | 1.158 | 4.192 | |
| Price To Book Ratio | 3.325 | 2.831 | 2.633 | 3.056 | 4.486 | |
| Price To Sales Ratio | 2.461 | 1.929 | 1.904 | 2.126 | 3.050 | |
| Price To Free Cash Flow Ratio | 103.289 | 30.665 | 33.897 | -45.418 | 49.866 | |
| Price To Operating Cash Flow Ratio | 31.043 | 19.111 | 16.345 | 253.063 | 28.992 | |
| Debt To Assets Ratio | 0.347 | 0.313 | 0.327 | 0.328 | 0.293 | |
| Debt To Equity Ratio | 0.652 | 0.597 | 0.625 | 0.651 | 0.545 | |
| Debt To Capital Ratio | 0.395 | 0.374 | 0.385 | 0.394 | 0.353 | |
| Long Term Debt To Capital Ratio | 0.382 | 0.366 | 0.380 | 0.387 | 0.349 | |
| Financial Leverage Ratio | 1.880 | 1.907 | 1.913 | 1.982 | 1.860 | |
| Working Capital Turnover Ratio | 2.137 | 2.238 | 2.137 | 2.453 | 2.669 | |
| Operating Cash Flow Ratio | 0.485 | 0.581 | 0.718 | 0.044 | 0.625 | |
| Operating Cash Flow Sales Ratio | 0.079 | 0.101 | 0.117 | 0.008 | 0.105 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.301 | 0.623 | 0.482 | -5.572 | 0.581 | |
| Debt Service Coverage Ratio | 5.555 | 4.396 | 4.566 | 5.954 | 8.696 | |
| Interest Coverage Ratio | 7.002 | 6.656 | 6.159 | 13.525 | 13.566 | |
| Short Term Operating Cash Flow Coverage Ratio | 11.671 | 7.918 | 12.608 | 0.592 | 17.006 | |
| Operating Cash Flow Coverage Ratio | 0.164 | 0.248 | 0.258 | 0.019 | 0.284 | |
| Capital Expenditure Coverage Ratio | 1.430 | 2.654 | 1.931 | 0.152 | 2.389 | |
| Dividend Paid And Capex Coverage Ratio | 0.804 | 1.224 | 1.080 | 0.081 | 1.139 | |
| Dividend Payout Ratio | 0.518 | 0.555 | 0.741 | 0.489 | 0.562 | |
| Enterprise Value Multiple | 17.560 | 14.331 | 15.990 | 14.783 | 21.146 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 33.5% | ▲0.9% | ▲0.5% |
| Ebit Margin | 12.8% | ▲0.5% | ▲0.5% |
| Ebitda Margin | 16.6% | ▲0.5% | ▲0.5% |
| Operating Profit Margin | 12.8% | ▲0.5% | ▲0.5% |
| Pretax Profit Margin | 11.0% | ▲0.6% | ▲0.1% |
| Continuous Operations Profit Margin | 8.3% | ▲0.3% | ▲0.1% |
| Net Profit Margin | 8.3% | ▲0.3% | ▲0.1% |
| Bottom Line Profit Margin | 8.3% | ▲0.3% | ▲0.1% |
| Current Ratio | 4.103 | ▲0.549 | ▲0.454 |
| Quick Ratio | 1.530 | ▲0.194 | ▲0.114 |
| Solvency Ratio | 0.186 | ▼-0.006 | ▼-0.003 |
| Cash Ratio | 0.139 | ▲0.040 | ▲0.029 |
| Price To Earnings Ratio | 29.544 | ▲5.470 | ▲1.438 |
| Price To Earnings Growth Ratio | 3.975 | ▲3.253 | ▲2.185 |
| Forward Price To Earnings Growth Ratio | 3.975 | ▲3.253 | ▲2.185 |
| Price To Earnings Diluted Ratio | 29.731 | ▲5.493 | ▲1.476 |
| Price To Earnings Diluted Growth Ratio | 3.973 | ▲3.239 | ▲2.138 |
| Price To Book Ratio | 3.325 | ▲0.494 | ▲0.059 |
| Price To Sales Ratio | 2.461 | ▲0.533 | ▲0.167 |
| Price To Free Cash Flow Ratio | 103.290 | ▲72.625 | ▲68.830 |
| Price To Operating Cash Flow Ratio | 31.043 | ▲11.932 | ▼-38.668 |
| Debt To Assets Ratio | 0.347 | ▲0.034 | ▲0.025 |
| Debt To Equity Ratio | 0.652 | ▲0.055 | ▲0.038 |
| Debt To Capital Ratio | 0.395 | ▲0.021 | ▲0.015 |
| Long Term Debt To Capital Ratio | 0.382 | ▲0.016 | ▲0.009 |
| Financial Leverage Ratio | 1.880 | ▼-0.027 | ▼-0.028 |
| Working Capital Turnover Ratio | 2.136 | ▼-0.102 | ▼-0.190 |
| Operating Cash Flow Ratio | 0.485 | ▼-0.096 | ▼-0.006 |
| Operating Cash Flow Sales Ratio | 0.079 | ▼-0.022 | ▼-0.003 |
| Free Cash Flow Operating Cash Flow Ratio | 0.300 | ▼-0.323 | ▲1.017 |
| Debt Service Coverage Ratio | 5.555 | ▲1.159 | ▼-0.278 |
| Interest Coverage Ratio | 7.002 | ▲0.346 | ▼-2.380 |
| Short Term Operating Cash Flow Coverage Ratio | 11.671 | ▲3.754 | ▲1.712 |
| Operating Cash Flow Coverage Ratio | 0.164 | ▼-0.084 | ▼-0.030 |
| Capital Expenditure Coverage Ratio | 1.430 | ▼-1.224 | ▼-0.281 |
| Dividend Paid And Capex Coverage Ratio | 0.804 | ▼-0.420 | ▼-0.062 |
| Dividend Payout Ratio | 0.518 | ▼-0.038 | ▼-0.055 |
| Enterprise Value Multiple | 17.560 | ▲3.230 | ▲0.798 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.97B | $3.00B | $2.77B | $3.05B | $4.21B | |
| Enterprise value | $4.71B | $3.61B | $3.40B | $3.68B | $4.70B | |
| EV / Sales | 2.92x | 2.32x | 2.34x | 2.56x | 3.40x | |
| EV / Op. cash flow | 36.85x | 22.97x | 20.06x | 305.24x | 32.34x | |
| EV / Free cash flow | 122.61x | 36.86x | 41.59x | -54.78x | 55.62x | |
| EV / EBITDA | 17.56x | 14.33x | 15.99x | 14.78x | 21.15x | |
| Net debt / EBITDA | 2.77x | 2.41x | 2.96x | 2.53x | 2.19x | |
| Current ratio | 4.10x | 3.55x | 3.96x | 3.44x | 3.19x | |
| Income quality | 0.95x | 1.26x | 1.82x | 0.09x | 1.22x | |
| Graham number | $45 | $41 | $35 | $42 | $38 | |
| Graham net-net | -$11 | -$10 | -$10 | -$11 | -$9 | |
| Tax burden | 75.7% | 76.6% | 71.9% | 77.3% | 75.4% | |
| Interest burden | 85.7% | 85.0% | 83.8% | 92.6% | 92.6% | |
| Working capital | $817.9M | $691.2M | $700.3M | $662.6M | $508.8M | |
| Invested capital | $1.27B | $1.61B | $1.64B | $1.58B | $1.39B | |
| Return on assets | 6.0% | 6.2% | 4.6% | 7.1% | 6.8% | |
| Operating ROA | 9.7% | 9.5% | 7.8% | 10.6% | 9.8% | |
| Return on tangible assets | 7.5% | 7.8% | 5.9% | 9.1% | 9.1% | |
| Return on equity | 11.3% | 11.8% | 8.9% | 14.1% | 12.7% | |
| Return on invested capital | 7.9% | 8.3% | 6.2% | 8.8% | 8.4% | |
| Return on capital employed | 10.5% | 10.9% | 8.7% | 11.5% | 11.2% | |
| Earnings yield | 3.4% | 4.2% | 3.4% | 4.6% | 2.8% | |
| Free cash flow yield | 1.0% | 3.3% | 3.0% | -2.2% | 2.0% | |
| Capex / Op. cash flow | 69.9% | 37.7% | 51.8% | 657.2% | 41.9% | |
| Capex / Depreciation | 146.3% | 98.1% | 152.0% | 151.2% | 116.8% | |
| Capex / Sales | 5.5% | 3.8% | 6.0% | 5.5% | 4.4% | |
| SG&A / Sales | 20.6% | 17.1% | 17.7% | 17.4% | 18.1% | |
| R&D / Sales | 0.0% | 3.2% | 3.3% | 2.9% | 2.5% | |
| Stock comp / Sales | 0.9% | 0.6% | 0.6% | 1.1% | 0.7% | |
| Intangibles / Total assets | 20.0% | 20.9% | 21.7% | 21.9% | 24.9% | |
| Days sales outstanding | 69d | 68d | 68d | 77d | 69d | |
| Days payables outstanding | 47d | 48d | 48d | 55d | 50d | |
| Operating cycle | 300d | 277d | 287d | 294d | 231d | |
| Cash conversion cycle | 253d | 228d | 239d | 239d | 182d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+32.1%EV / Sales ▲+26.0%EV / EBITDA ▲+22.5%EV / Op. cash flow ▲+13.876Earnings yield ▼-0.008Graham number ▲+4.062
Profitability
Return on equity ▼-0.005Return on assets ▼-0.002Return on invested capital ▼-0.004Return on capital employed ▼-0.005Operating ROA ▲+0.002Income quality ▼-0.310Tax burden ▼-0.008
Efficiency
Days sales outstanding ▲+1.148Days payables outstanding ▼-1.262Operating cycle ▲+23.247Cash conversion cycle ▲+24.510Capex / Sales ▲+0.017R&D / Sales ▼-0.032
Balance-sheet strength
Current ratio ▲+0.549Net debt / EBITDA ▲+0.358Working capital ▲+126618000.000Invested capital ▼-337202000.000Intangibles / Total assets ▼-0.009
Change over 5 years
Valuation
Market cap ▼-5.8%EV / Sales ▼-14.1%EV / EBITDA ▼-17.0%EV / Op. cash flow ▲+4.510Earnings yield ▲+0.006Graham number ▲+7.363
Profitability
Return on equity ▼-0.014Return on assets ▼-0.008Return on invested capital ▼-0.006Return on capital employed ▼-0.008Operating ROA ▼-0.001Income quality ▼-0.272Tax burden ▲+0.003
Efficiency
Days sales outstanding ▲+0.090Days payables outstanding ▼-2.433Operating cycle ▲+68.501Cash conversion cycle ▲+70.934Capex / Sales ▲+0.011R&D / Sales ▼-0.025
Balance-sheet strength
Current ratio ▲+0.912Net debt / EBITDA ▲+0.579Working capital ▲+309017000.000Invested capital ▼-121045000.000Intangibles / Total assets ▼-0.049
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-05 China SXT Pharmaceuticals, Inc. Announces Share Consolidation TAIZHOU, China, Aug. 05, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company”), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value per share, and Class B ordinary shares no par value per share, at a ratio of 1-for-80, effective on August 10, 2026 (the “Share Consolidation”). The Company''s Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on August 10, 2026.
- 2026-07-29 ADAR1 Capital Management LLC Takes Position in Sensient Technologies Corporation $SXT ADAR1 Capital Management LLC acquired a new position in Sensient Technologies Corporation (NYSE: SXT) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 15,000 shares of the specialty chemicals company''s stock, valued at approximately $1,297,000. Other large investors have also made changes
- 2026-07-28 Sensient (SXT) Upgraded to Strong Buy: Here''s What You Should Know Sensient (SXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 2026-07-28 Are Basic Materials Stocks Lagging Sensient Technologies (SXT) This Year? Here is how Sensient Technologies (SXT) and Reliance (RS) have performed compared to their sector so far this year.
- 2026-07-28 Sensient Technologies (NYSE:SXT) Sets New 1-Year High Following Earnings Beat Shares of Sensient Technologies Corporation (NYSE: SXT - Get Free Report) reached a new 52-week high during trading on Monday following a stronger than expected earnings report. The stock traded as high as $131.04 and last traded at $128.75, with a volume of 60940 shares changing hands. The stock had previously closed at $126.79. The specialty
- 2026-07-27 California Public Employees Retirement System Trims Position in Sensient Technologies Corporation $SXT California Public Employees Retirement System reduced its holdings in Sensient Technologies Corporation (NYSE: SXT) by 22.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 56,365 shares of the specialty chemicals company''s stock after selling 16,344 shares during the period. California Public
- 2026-07-26 Sensient Technologies Q2 Earnings Call Highlights Sensient Technologies (NYSE: SXT) reported second-quarter 2026 results marked by double-digit local-currency growth in revenue, adjusted EBITDA and adjusted earnings per share, as demand for natural color conversions continued to build ahead of U.S. regulatory deadlines. Chairman, President and Chief Executive Officer Paul Manning said the company delivered 10% local-currency revenue growth, 21% local-currency adjusted EBITDA
- 2026-07-24 Sensient Technologies Corporation (SXT) Q2 2026 Earnings Call Transcript Sensient Technologies Corporation (SXT) Q2 2026 Earnings Call Transcript
- 2026-07-24 Sensient Technologies Q2 Earnings Call Highlights Sensient Technologies NYSE: SXT reported second-quarter 2026 results marked by double-digit local-currency growth in revenue, adjusted EBITDA and adjusted earnings per share, as demand for natural color conversions continued to build ahead of U.S. regulatory deadlines.
- 2026-07-24 Sensient Technologies (SXT) Surpasses Q2 Earnings and Revenue Estimates Sensient Technologies (SXT) came out with quarterly earnings of $1.2 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $0.94 per share a year ago.